Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Newly made nicotinamide compounds could potentially treat cancer.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Oral cyclosporin doesn't stop hair loss.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Minoxidil caused hair regrowth, but cyproterone acetate did not maintain it.